Acute and Secondary Management of Stroke
For acute ischemic stroke, immediately administer intravenous alteplase (0.9 mg/kg, maximum 90 mg) within 3-4.5 hours of symptom onset for eligible patients, followed by aspirin 325 mg within 24-48 hours, and consider endovascular thrombectomy up to 24 hours for large vessel occlusions. 1, 2
Immediate Acute Management (First Hours)
Prehospital and Emergency Department Priorities
Stroke must be treated as a life-threatening emergency requiring immediate action 3. The primary goals are:
- Airway, breathing, and circulation support - especially for seriously ill or comatose patients 3
- Blood pressure management - lower elevated BP cautiously, not aggressively 3
- Urgent neuroimaging - CT or MRI to differentiate ischemic from hemorrhagic stroke and determine treatment eligibility 1
Reperfusion Therapy: The Critical Window
Intravenous Thrombolysis
Alteplase is the only approved thrombolytic agent for acute ischemic stroke 1. Administration protocol:
- Dose: 0.9 mg/kg (maximum 90 mg total)
- 10% as IV bolus over 1 minute
- Remaining 90% as infusion over 60 minutes 1
- Time window: Within 3-4.5 hours of symptom onset 3, 2
- Target: Door-to-needle time <60 minutes in 90% of patients, median 30 minutes 1
Critical caveat: This dosing differs from myocardial infarction protocols 1. Streptokinase and other thrombolytics cannot be safely substituted 3.
Endovascular Thrombectomy (EVT)
For patients with proximal anterior circulation large vessel occlusions:
- Extended time window: Up to 24 hours from symptom onset in selected patients 1, 2
- Can be performed with or without prior thrombolysis 1
- Selection criteria: Use CT/MR perfusion to demonstrate salvageable tissue, especially beyond 6 hours 1
Antiplatelet Therapy
Aspirin 325 mg should be administered within 24-48 hours after stroke onset 4. This provides modest benefit primarily through prevention of early recurrent stroke 4.
Important restrictions:
- Do NOT give aspirin within 24 hours of alteplase administration 4
- Aspirin is not a substitute for thrombolysis 4
- Dual antiplatelet therapy (aspirin + clopidogrel) is only recommended short-term for minor stroke/high-risk TIA 1, 5
What NOT to Do
Avoid these interventions - they increase harm without benefit:
- Urgent anticoagulation (heparin, LMWH) - does not prevent early recurrent stroke but increases hemorrhagic risk 4
- Corticosteroids for cerebral edema - not recommended (Grade A) 3
- Neuroprotective medications - none have proven effective 3
- Prophylactic anticonvulsants - only treat actual seizures 3
Management of Complications
Increased Intracranial Pressure
For patients deteriorating from elevated ICP or herniation 3:
- Osmotherapy and hyperventilation (Grade B recommendation)
- Surgical decompression for:
- Large cerebellar infarctions causing brainstem compression (Grade C)
- Massive hemispheric infarction (life-saving but leaves severe deficits) (Grade C)
- Hydrocephalus requiring CSF drainage (Grade C)
Hemorrhagic Transformation
Approximately 5% of infarctions develop symptomatic hemorrhagic transformation 3. Management depends on bleeding severity and symptoms. All antithrombotics increase this risk, especially anticoagulants and thrombolytics 3.
For alteplase-associated bleeding 1:
- Insufficient evidence for routine use of cryoprecipitate, FFP, prothrombin complex concentrates, tranexamic acid, or factor VIIa
- Decisions must be individualized
- For angioedema: staged response with antihistamines, glucocorticoids, and airway management
Secondary Prevention (First 48 Hours to 2 Weeks)
Risk Factor Modification
Hypertension management is paramount 5. Other critical targets include:
- Diabetes control
- Lipid management
- Smoking cessation
- Mediterranean or low-salt diet 5
Long-term Antithrombotic Strategy
The choice depends on stroke etiology 5:
For atrial fibrillation: Anticoagulation is usually recommended if no contraindications exist 5. Consider extended cardiac monitoring if no stroke cause identified.
For non-cardioembolic stroke: Continue antiplatelet therapy 5. The combination of antiplatelet + anticoagulation is typically NOT indicated for secondary prevention 5.
Stroke Unit Care
Comprehensive stroke unit care with early rehabilitation should be provided to a broad spectrum of patients 3. This includes:
- Prevention and treatment of medical/neurological complications
- Evaluation to determine stroke etiology
- Institution of therapies to prevent recurrence
- Early rehabilitation planning 3
Key Clinical Pitfalls to Avoid
Time delays: Every minute counts - "time is brain." Organize regional systems to expedite care 3
Wrong thrombolytic dose: Stroke dosing (0.9 mg/kg) differs from MI protocols 1
Premature anticoagulation: Increases hemorrhage risk without reducing early recurrence 4
Aspirin timing error: Wait 24 hours after alteplase 4
Missing EVT candidates: Consider thrombectomy up to 24 hours with appropriate imaging selection 1, 2
Patients on DOACs: Alteplase should not routinely be given; consider EVT instead 1